Phytecs
Biotechnology ResearchCalifornia, United States0-1 Employees
Phytecs is a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system (ECS).
Innovative Niche Focus Phytecs operates within the specialized biotechnology research sector targeting the human endocannabinoid system, presenting opportunities to supply advanced research tools, laboratory equipment, and specialized compounds to support their cutting-edge studies.
Research Collaboration Potential The company's active collaboration with global researchers and presentation at major conferences indicates openness to joint ventures, licensing, or research partnerships that can help scale their product development efforts.
Growth Revenue Range With estimated revenues between $1 million and $10 million, Phytecs is a growing entity that may benefit from tailored investment solutions, research grants, or strategic technology partnerships to accelerate their product pipeline.
Technological Capabilities Their use of modern tech stacks like MySQL, PHP, and OpenSSL suggests a focus on data management and secure digital platforms, opening opportunities for IT hardware, cybersecurity solutions, and cloud services tailored for biotech research.
Market Expansion Opportunities Given the emerging interest in cannabinoid-based therapies demonstrated by their studies and presentations, there is a potential to support Phytecs in clinical trial services, regulatory compliance, and commercialization strategies for their novel therapeutics.
Phytecs uses 8 technology products and services including MySQL, Font Awesome, Google Fonts API, and more. Explore Phytecs's tech stack below.
| Phytecs Email Formats | Percentage |
| FLast@phytecs.com | 100% |
Biotechnology ResearchCalifornia, United States0-1 Employees
Phytecs is a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system (ECS).
Phytecs's revenue is estimated to be in the range of $1M$10M
Phytecs's revenue is estimated to be in the range of $1M$10M